Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisation.

Jessica L WisnowskiStefan BlumlAshok PanigrahyAmit M MathurJeffrey BermanPing-Sun Keven ChenJames DixTrevor FlynnStanley FrickeSeth D FriedmanHayden W HeadChang Y HoBeth Kline-FathMichael OvesonRichard PattersonSumit PruthiNancy RollinsYanerys M RamosJohn RamptonJerome RusinDennis W ShawMark SmithJean TkachShreyas VasanawalaArastoo VossoughMatthew T WhiteheadDuan XuKristen YeomBryan ComstockPatrick J HeagertySandra E JuulYvonne W WuRobert C McKinstrynull null

Published in: BMJ open (2021)

NCT02811263; Pre-result.

Keyphrases

high dose
study protocol
clinical trial
randomized controlled trial
phase iii
phase ii
low dose
stem cell transplantation
early onset
double blind
recombinant human
open label
cross sectional